Thromboelastography as a Better Indicator of Hypercoagulable State After Injury Than Prothrombin Time or Activated Partial Thromboplastin Time

被引:316
作者
Park, Myung S. [1 ]
Martini, Wenjun Z. [1 ]
Dubick, Michael A. [1 ]
Salinas, Jose [1 ]
Butenas, Saulius [2 ]
Kheirabadi, Bijan S. [1 ]
Pusateri, Anthony E. [1 ]
Vos, Jeffrey A. [3 ]
Guymon, Charles H. [1 ]
Wolf, Steven E. [1 ]
Mann, Kenneth G. [2 ]
Holcomb, John B. [1 ]
机构
[1] USA, Inst Surg Res, Ft Sam Houston, TX 78234 USA
[2] Univ Vermont, Dept Biochem, Burlington, VT 05405 USA
[3] W Virginia Univ, Dept Pathol, Morgantown, WV 26506 USA
来源
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE | 2009年 / 67卷 / 02期
关键词
Deep vein thrombosis; Pulmonary embolism; Thromboelastograph; RETRACTED ARTICLE. SEE; DEEP-VEIN THROMBOSIS; TISSUE-FACTOR; FACTOR-XI; HYPOTHERMIC COAGULOPATHY; VENOUS THROMBOEMBOLISM; ANTITHROMBIN-III; FACTOR XA; PG; 29067; COAGULATION;
D O I
10.1097/TA.0b013e3181ae6f1c
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives: To investigate the hemostatic status of critically ill, nonbleeding trauma patients. We hypothesized that a hypercoagulable state exists in patients early after severe injury and that the pattern of clotting and fibrinolysis are similar between burned and nonburn trauma patients. Materials: Patients admitted to the Surgical or burn intensive care unit within 24 hours after injury were enrolled. Blood samples were drawn on days 0 through 7. Laboratory tests included prothrombin time (PT). activated partial thromboplastin time (aPTT), levels of activated factor XI, D-dimer, protein C percent activity, antithrombin III percent activity, and thromboelastography (TEG). Results: Study subjects were enrolled front April 1, 2004, to May 3 1, 2005, and included nonburn trauma patients (n = 33), burned patients (n = 25) and healthy (control) subjects (n = 20). Despite aggressive thromboprophylaxis, three subjects (12 burned and I nonburn trauma patients [6%]) had pulmonary embolism during hospitalization. Compared with controls, all patients had prolonged PT and aPTT (p < 0.05). The rate of clot formation (a angle) and maximal clot strength were higher for patients compared with those of controls (p < 0.05), indicating a hypercoagulable state. Injured patients also had lower protein C and antithrombin III percent activities and higher fibrinogen levels (p < 0.05 for all). Activated factor XI was elevated in 38% of patients (control subjects had undetectable levels). Discussion: Thromboelastography analysis of whole blood showed that patients were in a hypercoagulable state; this was not detected by plasma PT or aPTT. The high incidence of pulmonary embolism indicated that our Current prophylaxis regimen could be improved.
引用
收藏
页码:266 / 275
页数:10
相关论文
共 50 条
[31]   Effect of Subcutaneous Unfractionated Heparin Prophylaxis on Activated Partial Thromboplastin Time: A Retrospective Evaluation [J].
Thompson, Molly H. ;
Wilson, Sylvia H. ;
Toussaint, Brittany L. ;
Jordan, Cameron L. ;
Hayes, Genevieve L. ;
McKinzie, Brian P. ;
Wolf, Bethany J. ;
Field, Larry C. .
JOURNAL OF CLINICAL ANESTHESIA, 2016, 33 :346-350
[32]   A laboratory evaluation into the short activated partial thromboplastin time [J].
Mina, Ashraf ;
Favaloro, Emmanuel J. ;
Mohammed, Soma ;
Koutts, Jerry .
BLOOD COAGULATION & FIBRINOLYSIS, 2010, 21 (02) :152-157
[33]   The evaluation of prothrombin time and activated partial thromboplastin time among diabetic and healthy controls in Africa: systematic review and meta-analysis [J].
Getu, Fasil ;
Alemayehu, Ermiyas ;
Tesfaye, Addisu ;
Genanew, Birhanu ;
Walle, Muluken .
FRONTIERS IN MEDICINE, 2024, 11
[34]   One-stage prothrombin time, activated partial thromboplastin time, thrombin time, fibrin degradation product concentration, and antithrombin activity in healthy adult alpacas [J].
House, Amanda M. ;
Barton, Michelle H. ;
Williamson, Lisa H. .
VETERINARY CLINICAL PATHOLOGY, 2011, 40 (02) :195-197
[35]   Implications of deranged activated partial thromboplastin time for anaesthesia and surgery [J].
Loizou, E. ;
Mayhew, D. J. ;
Martlew, V. ;
Murthy, B. V. S. .
ANAESTHESIA, 2018, 73 (12) :1557-1563
[36]   Prothrombin time and activated partial thromboplastin time using a point-of-care analyser (Abaxis VSpro®) in Bennett's wallabies (Macropus rufogriseus) [J].
Nevitt, B. N. ;
Chinnadurai, S. K. ;
Watson, M. K. ;
Langan, J. N. ;
Adkesson, M. J. .
AUSTRALIAN VETERINARY JOURNAL, 2016, 94 (10) :384-386
[37]   Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time [J].
Hron, G ;
Eichinger, S ;
Weltermann, A ;
Quehenberger, P ;
Halbmayer, WM ;
Kyrle, PA .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (04) :752-756
[38]   Evaluating the analytical performance of five new coagulation assays for the measurement of prothrombin time and activated thromboplastin time [J].
Kitchen, Steve ;
Geisen, Ulrich ;
Kappelmayer, Janos ;
Quehenberger, Peter ;
Driess, Julia ;
Lowe, Anna ;
Jones, Robert ;
Boehm, Jana G. ;
Miles, Gabrielle ;
Rozsnyai, Gergely .
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2018, 40 (06) :645-654
[39]   BEDSIDE MONITORING OF HEPARIN-THERAPY - COMPARISON OF ACTIVATED CLOTTING TIME TO ACTIVATED PARTIAL THROMBOPLASTIN TIME [J].
REINER, JS ;
COYNE, KS ;
LUNDERGAN, CF ;
ROSS, AM .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1994, 32 (01) :49-52
[40]   The clinical significance of a shortened activated partial thromboplastin time in patients with connective tissue disease [J].
Habe, Koji ;
Wada, Hideo ;
Mizutani, Kento ;
Matsushima, Yoshiaki ;
Kondo, Makoto ;
Yamanaka, Keiichi .
CLINICAL RHEUMATOLOGY, 2021, 40 (11) :4675-4683